Ravidasvir
Showing 1 - 10 of 10
Hepatitis C Trial in Alor Star (Sofosbuvir 400 MG, Ravidasvir 200mg)
Recruiting
- Hepatitis C
- Sofosbuvir 400 MG
- Ravidasvir 200mg
-
Alor Star, Kedah, MalaysiaHospital Sultanah Bahiyah
May 17, 2021
Healthy Trial in Changsha (ASC18, ravidasvir and sofosbuvir)
Completed
- Healthy
- ASC18
- ravidasvir and sofosbuvir
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Jan 7, 2021
HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)
Completed
- HCV
- Ravidasvir
- +7 more
-
Beijing, Beijing, ChinaPeking University People's hospital
Jul 25, 2020
Hepatitis C Trial in Malaysia, Thailand (sofosbuvir + ravidasvir)
Active, not recruiting
- Hepatitis C
- sofosbuvir + ravidasvir
-
Johor Bahru, Johor, Malaysia
- +12 more
Jan 18, 2021
Bioequivalence Study Trial in Ampang (Ravidasvir test formulation produced by Doppel, Ravidasvir reference formulation produced
Completed
- Bioequivalence Study
- Ravidasvir test formulation produced by Doppel
- Ravidasvir reference formulation produced by EEPI
-
Ampang, Selangor, MalaysiaAmpang hospital
Jan 30, 2020
Healthy Trial (Ravidasvir, Danoprevir, Ritonavir)
Completed
- Healthy
- Ravidasvir
- +3 more
- (no location specified)
Jun 27, 2018
Chronic Hepatitis c Trial in Hangzhou (Ravidasvir 50mg, Ravidasvir 200mg)
Completed
- Chronic Hepatitis c
- Ravidasvir 50mg
- Ravidasvir 200mg
-
Hangzhou, Zhejiang, ChinaFirst Hospital of Zhejiang Province
Jun 27, 2018
HCV Trial in Hangzhou (Danoprevir, Ritonavir, Ravidasvir)
Completed
- HCV
- Danoprevir
- +3 more
-
Hangzhou, Zhejiang, ChinaThe first hospital of Zhejiang province
Jan 14, 2018
Chronic Hepatitis C Trial in Cairo, Menoufiya (ravidasvir HCl, sofosbuvir, ribavirin)
Unknown status
- Chronic Hepatitis C
- ravidasvir hydrochloride
- +2 more
-
Cairo, Egypt
- +2 more
Apr 6, 2016